Featured Research

from universities, journals, and other organizations

Schools failing pupils with sickle cell disease, U.K. study suggests

Date:
July 20, 2011
Source:
Economic and Social Research Council (ESRC)
Summary:
A new study suggests young people with a serious genetic blood disorder are not getting the right help at school, especially pupils who miss lessons due to sickness.

A new study suggests young people with a serious genetic blood disorder are not getting the right help at school, especially pupils who miss lessons due to sickness.

Research funded by the Economic and Social Research Council (ESRC) at De Montfort University, the University of York and Loughborough University reveals that most children with sickle cell disease (SCD) do not feel supported by schools in catching up on absences from class.

Sickle cell is an inherited condition affecting around one in every 2,000 children born in England. The majority are from ethnic minority backgrounds and those with the disease may develop abnormal shaped red blood cells which block blood vessels. This can lead to chronic pain, organ damage and even strokes.

A common assumption has been that raising awareness in teachers about sickle cell is enough. Yet Professor Simon Dyson from De Montfort and the research team found no link between a school knowing a pupil has SCD and the child reporting improved experiences at school.

The study also found that young people are divided on whether others at school should be told they have SCD. Some believe this will lead to help, other pupils feel it will intensify bullying.

"Many schools are failing to keep young people well, and are not supporting them to catch-up any schooling they miss through illness," says Professor Simon Dyson who works in the Unit for the Social Study of Thalassaemia and Sickle Cell at De Montfort.

Professor Dyson and his researchers have developed a policy guide for schools on supporting children with medical conditions. The Department for Education have since used this information in a health and safety leaflet targeting educators.

The guide highlights examples of good practice where schools have adjusted their approach or policies to improve support for young people with SCD. Often this includes providing assistance but without drawing attention to pupils with the condition and not labelling pupils with SCD as 'truants' if they are persistently absent, or not forcing children who are tired or in pain to take exercise.

One school instigated a system of issuing the young person with a laminated card stating that the young person has the right to excuse themselves during lesson in order to go the toilet. Another school has a policy of regular twilight catch-up sessions after school. This learning centre is staffed on a rota basis so that any pupil who has missed a lesson for any reason can catch up in the presence of teachers, which doesn't single out the SCD student.

The impact of SCD on the educational experiences of young people is an under-researched area. Schools do have a duty to ensure the health and safety of pupils under the Health and Safety at Work Act, but previous studies have shown that pupils can miss weeks of schooling a year if schools and colleges do not have the correct support in place.

Professor Dyson comments: "Good practice consists of changing the wider school environment in the background without drawing attention to the young person with sickle cell as different from others. Being seen as different is something young people with sickle cell hate."


Story Source:

The above story is based on materials provided by Economic and Social Research Council (ESRC). Note: Materials may be edited for content and length.


Cite This Page:

Economic and Social Research Council (ESRC). "Schools failing pupils with sickle cell disease, U.K. study suggests." ScienceDaily. ScienceDaily, 20 July 2011. <www.sciencedaily.com/releases/2011/07/110720085515.htm>.
Economic and Social Research Council (ESRC). (2011, July 20). Schools failing pupils with sickle cell disease, U.K. study suggests. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/07/110720085515.htm
Economic and Social Research Council (ESRC). "Schools failing pupils with sickle cell disease, U.K. study suggests." ScienceDaily. www.sciencedaily.com/releases/2011/07/110720085515.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins